Page 5 - விஸ் ஸ்தாபகம் இயக்குனர் டொனால்ட் இங்க்பேற் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from விஸ் ஸ்தாபகம் இயக்குனர் டொனால்ட் இங்க்பேற். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In விஸ் ஸ்தாபகம் இயக்குனர் டொனால்ட் இங்க்பேற் Today - Breaking & Trending Today

Electrochemical Sensor Platform for Fast, Sensitive Detection of Biomarkers in Whole Blood


Electrochemical Sensor Platform for Fast, Sensitive Detection of Biomarkers in Whole Blood
Written by AZoSensorsFeb 15 2021
Many life-threatening medical conditions, such as sepsis, which is triggered by blood-borne pathogens, cannot be detected accurately and quickly enough to initiate the right course of treatment.
In patients that have been infected by an unknown pathogen and progress to overt sepsis, every additional hour that an effective antibiotic cannot be administered significantly increases the mortality rate, so time is of utmost essence.
The challenge with rapidly diagnosing sepsis stems from the fact that measuring only one biomarker often does not allow a clear-cut diagnosis. Engineers have struggled for decades to simultaneously quantify multiple biomarkers in whole blood with high specificity and sensitivity for point-of-care (POC) diagnostic applications as this would avoid time-consuming and costly blood processing steps in which informative biom ....

United States , United Kingdom , Despina Moschou , Pawan Jolly , Pedro Estrela , Donald Ingber , Harvard Wyss Institute For Biologically Inspired Engineering , Wyss Institute , University Of Bath , Wyss Institute Bioinspired Therapeutics , Defense Advanced Research Projects Agency , Us Army Research Office , Centre For Biosensors , Biologically Inspired Engineering , Wyss Founding Director Donald Ingber , Wyss Senior Staff Scientist Pawan Jolly , Advanced Functional , Bioinspired Therapeutics , Judah Folkman Professor , Vascular Biology , Harvard Medical School , Boston Children , Nature Nanotechnology , Harvard University , Rosetrees Trust , ஒன்றுபட்டது மாநிலங்களில் ,

New diagnostic platform can rapidly measure COVID-19-related biomarkers


New diagnostic platform can rapidly measure COVID-19-related biomarkers
The Wyss Institute for Biologically Inspired Engineering at Harvard University and GBS Inc., a subsidiary of The iQ Group Global, announce that they will collaborate to validate and de-risk a specific and sensitive COVID-19 diagnostic that would integrate the Institute s eRapid technology with the company s proprietary transistor sensor technology to enable simultaneous electrochemical sensing of multiple biomarkers related to SARS-CoV-2 infection in point-of-care COVID-19 diagnostic applications.
The research collaboration further cements both parties commitment to bringing the Wyss multiplexed electrochemical detection system forward as a diagnostic tool during the pandemic and follows a licensing agreement coordinated by Harvard s Office of Technology Development (OTD) in November 2020 that granted The iQ Group Global non-exclusive, term-limited access to the eRapid technology in accordance with t ....

United States , George Syrmalis , Pawan Jolly , Paul Dastoor , Donald Ingber , Emily Henderson , School Of Mathematical , Technology Access Framework , Wyss Institute , Wyss Institute Bioinspired Therapeutics , Harvard Office Of Technology Development , Harvard Johna Paulson School Of Engineering , University Of Newcastle , Iq Group Global , Biologically Inspired Engineering , Harvard University , Technology Development , Wyss Founding Director Donald Ingber , Bioinspired Therapeutics , Judah Folkman Professor , Vascular Biology , Harvard Medical School , Boston Children , Harvard John , Wyss Senior Staff Scientist Pawan Jolly , Organic Thin Film Transistor ,

Harvard's Wyss Institute collaborates with GBS Inc. on the Wyss' eRapid-based COVID-19 diagnostic to help curb the pandemic


Share this article
Share this article
BOSTON, Feb. 17, 2021 /PRNewswire/  The Wyss Institute for Biologically Inspired Engineering at Harvard University and GBS Inc., a subsidiary of The iQ Group Global, announce that they will collaborate to validate and de-risk a specific and sensitive COVID-19 diagnostic that would integrate the Institute s eRapid technology with the company s proprietary transistor sensor technology to enable simultaneous electrochemical sensing of multiple biomarkers related to SARS-CoV-2 infection in point-of-care COVID-19 diagnostic applications.
The Wyss Institute collaborates with GBS Inc., a subsidiary of The iQ Group Global, to combine its electrochemical eRapid sensing technology with GBS’s transistor technology in developing a multiplexed COVID-19 biomarker diagnostic. Credit: Wyss Institute at Harvard University ....

Boston University , United States , University Of Massachusetts Medical School , Massachusetts Institute Of Technology , Harvard University , Tufts University , Spaulding Rehabilitation Hospital , George Syrmalis , Pawan Jolly , Paul Dastoor , James Gorman , Donald Ingber , Benjamin Boettner , Gemma Garkut , Beth Israel Deaconess Medical Center , Wyss Institute , Harvard Johna Paulson School Of Engineering , University Of Zurich , Iq Group Global , School Of Mathematical , Farber Cancer Institute , Arts Sciences , Harvard University Office Of Technology Development , Wyss Institute Bioinspired Therapeutics , Sciences Engineering Accelerator , University Of Newcastle ,

Harvard's Wyss Institute collaborates with GBS Inc. on eRapid-based COVID-19 diagnostic


 E-Mail
IMAGE: The Wyss Institute collaborates with GBS Inc., a subsidiary of The iQ Group Global, to combine its electrochemical eRapid sensing technology with the GBS s transistor technology in developing a multiplexed.
view more 
Credit: Wyss Institute at Harvard University
(BOSTON) The Wyss Institute for Biologically Inspired Engineering at Harvard University and GBS Inc., a subsidiary of The iQ Group Global, announce that they will collaborate to validate and de-risk a specific and sensitive COVID-19 diagnostic that would integrate the Institute s eRapid technology with the company s proprietary transistor sensor technology to enable simultaneous electrochemical sensing of multiple biomarkers related to SARS-CoV-2 infection in point-of-care COVID-19 diagnostic applications. ....

Boston University , United States , University Of Massachusetts Medical School , Massachusetts Institute Of Technology , Harvard University , Dana Farber Cancer Institute , Tufts University , Spaulding Rehabilitation Hospital , George Syrmalis , Pawan Jolly , Paul Dastoor , James Gorman , Donald Ingber , Benjamin Boettner , Gemma Garkut , Beth Israel Deaconess Medical Center , Wyss Institute , Harvard Office Of Technology Development , Harvard Johna Paulson School Of Engineering , University Of Zurich , Iq Group Global , School Of Mathematical , Arts Sciences , Technology Access Framework , Harvard University Office Of Technology Development , Wyss Institute Bioinspired Therapeutics ,